ZK-186619

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameZK-186619
Drug Alias NameSERM (Schering AG)selective estrogen recpetor modulator (Schering AG)ZK-186619
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEstrogen receptor alpha modulators
TargetsEstrogen receptor alpha
Therapy Area/IndicationsEndometriosisOsteoporosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBayer Schering Pharma AG
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBayer Schering Pharma AG
Active IndicationsN/A
Inactive IndicationsEndometriosisOsteoporosis

Other Information

ATC CodeN/A
Related LinksN/A